In a letter to the chief secretaries, the National Pharmaceutical Pricing Authority (NPPA) has asked them to ensure that there is no violation to the provisions of the Drug Pricing Control Order (DPCO) with regard to compliance of selling price.from Industry-Economic Times
Read The Rest:economictimes...
